Annual report pursuant to Section 13 and 15(d)

Organization and Business

v2.4.1.9
Organization and Business
12 Months Ended
Dec. 31, 2014
Organization and Business  
Organization and Business

 

2.Organization and Business

 

Business Summary

 

AxoGen is a leading medical technology company dedicated to peripheral nerve repair.  Peripheral nerves provide the pathways for both motor and sensory signals throughout the body and their damage can result in the loss of function and feeling. In order to improve surgical repair and regeneration of peripheral nerves, AxoGen has developed and licensed regenerative medicine technologies. AxoGen’s innovative approach to regenerative medicine has resulted in first-in-class products that it believes are redefining the peripheral nerve repair market. AxoGen’s products offer a full suite of surgical nerve repair solutions including Avance® Nerve Graft, a proprietary off-the-shelf processed nerve allograft (human nerve tissue obtained from a donor) used for bridging severed nerves without the comorbidities associated with a nerve autograft additional surgical site, AxoGuard® Nerve Connector, a porcine submucosa ExtraCellular Matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. AxoGen also sells AxoTouchTM Two Point Discriminator, a measurement tool for determining innervation density and sensory function.